TOVX: Theriva Biologics, Inc. Stock

by  •  • Comments Off on TOVX: Theriva Biologics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 7.03
Enterprise Value ($M) -13.19
Book Value ($M) 39.70
Book Value / Share 2.31
Price / Book 0.18
NCAV ($M) 11.88
NCAV / Share 0.69
Price / NCAV 0.59

Profitability (mra)
Return on Invested Capital (ROIC) -0.44
Return on Assets (ROA) -0.27
Return on Equity (ROE) -0.36

Liquidity (mrq)
Quick Ratio 4.07
Current Ratio 4.07

Balance Sheet (mrq) ($M)
Current Assets 27.40
Assets 55.22
Liabilities 15.52
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -21.43
Net Income -18.35
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -19.00
Cash from Investing -0.20
Cash from Financing 0.62

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-25 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2023-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2023-05-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 11,423 153,424 7.45
2024-04-25 92,338 312,064 29.59
2024-04-24 26,708 122,599 21.78
2024-04-23 92,423 1,193,488 7.74

(click for more detail)

Similar Companies
PLX – Protalix BioTherapeutics, Inc. PTN – Palatin Technologies, Inc.
SCPX – Scorpius Holdings, Inc. VCXB – 10X Capital Venture Acquisition Corp. III
VNRX – VolitionRx Limited


Financial data and stock pages provided by
Fintel.io